U.S. stock benchmarks headed lower Tuesday morning, giving up some of Monday's gains, amid fresh concerns that the new omicron strain of coronavirus is more resistant to the current batch of vaccines. Moderna (NAS:MRNA) Chief Executive Stéphane Bancel told the Financial Times in an interview. The Dow Jones Industrial Average (DOW:DJIA) was down 0.8%, the S&P 500 index (S&P:SPX) declined 0.6% at 4,627, while the Nasdaq Composite Index (NASDAQ:COMP) retreated 0.4% at 15,717. The 10-year benchmark Treasury note was yielding 1.44%, down from 1.529% on Monday at 3 p.m. Eastern Time.
Nov. 30, 2021, 9:33 a.m. EST